|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.20 SAR | -0.50% |
|
-1.57% | +5.58% |
| 02-02 | Morgan Stanley Begins Nahdi Medical's Coverage at Overweight | MT |
| 01-29 | Citi Upgrades Nahdi Medical to Buy | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 2.52B | 8.69% | 9.24% | 32.51% | 14.22% | 0.36x | ||
| 7.97B | 7.16% | 2.54% | 7.96% | 6.14% | -13.27x | ||
| 4.22B | 4.68% | 4.83% | 9.28% | 7.01% | -5.08x | ||
| 148B | -5.85% | 1.78% | 12.35% | -9.72% | 1.61x | ||
| 7.09B | 5.15% | 7.73% | 10.6% | 12% | -1.05x | ||
| 2.71B | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | ||
| 3.3B | 6.35% | 9.16% | 14.67% | 5.87% | -0.92x | ||
| 8.55B | 1.16% | 2.83% | 6.2% | 2.64% | 0.74x | ||
| 3.63B | 3.45% | 5.66% | 13.17% | 3.5% | -0.4x | ||
| 5.77B | 4.08% | 6.46% | 20.43% | - | -0.49x | ||
| 1.23B | -8.96% | -5.12% | - | - | - | ||
| 2.11B | 3.01% | 5.37% | 24.33% | 6.42% | 1.74x | ||
| 2.45B | -1.92% | -1.47% | -9.04% | -4.49% | 4.52x | ||
| 2.47B | 0.63% | 1.54% | 1.5% | 0.68% | -1.05x | ||
| 718M | 2.45% | 3.87% | 9.06% | - | -0.92x | ||
| 1.72B | 5.74% | 7.97% | 26.73% | 7.6% | 2.29x | ||
| Average | 12.76B | 2.66% | 4.51% | 15.26% | 5.14% | -0.83x | |
| Weighted average by Cap. | 22.58B | 3.71% | 4.34% | 13.42% | 5.02% | -4.42x |
- Stock Market
- Equities
- 4164 Stock
- Sector Nahdi Medical Company
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















